Hudson Bay Capital Management
SWTX

Hudson Bay Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Hudson Bay Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,529,200
Closed -$166M – 1655
2025
Q2 		$166M Buy
+3,529,200
New +$157M 0.56% 35

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hudson Bay Capital Management's SWTX Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 547,010 shares — an estimated $25.7M sold.

Hudson Bay Capital Management first reported a position in SWTX in Q3 2024 and held it in 4 quarters. The position peaked at $25.7M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • Hudson Bay Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 547,010 SpringWorks Therapeutics shares in Q3 2025, an estimated $25.7M.
  • Hudson Bay Capital Management first reported a position in SpringWorks Therapeutics in Q3 2024 and held it in 4 quarters.
  • Hudson Bay Capital Management's SpringWorks Therapeutics position peaked at $25.7M in Q2 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.